We are live on ! Find out more
CCI

Columbus Circle Investors Portfolio holdings

AUM $2.28B
1-Year Est. Return 135.57%
This Fund
S&P 500
This Quarter Est. Return
+11.3%
1 Year Est. Return
+135.57%
3 Year Est. Return
+366.4%
5 Year Est. Return
+795.38%
10 Year Est. Return
AUM
$14.1B
AUM Growth
+$208M
Cap. Flow
-$745M
Cap. Flow %
-5.27%
Top 10 Hldgs %
23.71%
Holding
357
New
97
Increased
86
Reduced
104
Closed
70

Top Sells

Rank Stock Value
1
HAL icon
Halliburton
HAL
+$252M
2
AXP icon
American Express
AXP
+$177M
3
BIIB icon
Biogen
BIIB
+$177M
4
MAS icon
Masco
MAS
+$143M
5
BKNG icon
Booking.com
BKNG
+$120M

Sector Composition

Rank Sector Weight
1 Healthcare 24.9%
2 Technology 19.27%
3 Consumer Discretionary 17.25%
4 Financials 10.81%
5 Industrials 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWKS icon
226
Skyworks Solutions
SWKS
$10.6B
$6.35M 0.04%
87,350
-380,338
-81% -$23.6M
ARRY
227
DELISTED
Array Biopharma Inc
ARRY
$6.11M 0.04%
1,292,428
+535,050
+71% +$2.12M
WSM icon
228
Williams-Sonoma
WSM
$29.6B
$6.08M 0.04%
160,598
-323,512
-67% -$11.2M
UNH icon
229
UnitedHealth
UNH
$370B
$5.83M 0.04%
57,694
-89,585
-61% -$8.49M
ACOR
230
DELISTED
Acorda Therapeutics
ACOR
$5.72M 0.04%
1,166
+341
+41% +$1.46M
SAM icon
231
Boston Beer
SAM
$1.92B
$5.47M 0.04%
+18,888
New +$4.78M
INCY icon
232
Incyte
INCY
$24.4B
$5.29M 0.04%
+72,357
New +$4.73M
AAC
233
DELISTED
AAC Holdings
AAC
$4.1M 0.03%
+132,594
New +$3.37M
HABT
234
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
$3.97M 0.03%
+122,775
New +$4.29M
ACHN
235
DELISTED
Achillion Pharmaceuticals
ACHN
$3.89M 0.03%
317,766
+158,181
+99% +$1.93M
TGTX icon
236
TG Therapeutics
TGTX
$7.62B
$3.64M 0.03%
229,731
-227,981
-50% -$2.97M
P
237
DELISTED
Pandora Media Inc
P
$3.25M 0.02%
182,420
-2,875,503
-94% -$56.9M
ATRC icon
238
AtriCure
ATRC
$2.11B
$3.05M 0.02%
152,630
-12,378
-8% -$212K
KO icon
239
Coca-Cola
KO
$375B
$2.88M 0.02%
+68,300
New +$2.92M
QURE icon
240
uniQure
QURE
$3.22B
$2.7M 0.02%
182,194
+57,873
+47% +$708K
SGMO
241
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$2.51M 0.02%
+165,068
New +$2M
AERI
242
DELISTED
Aerie Pharmaceuticals
AERI
$2.51M 0.02%
85,932
-34,685
-29% -$880K
INSM icon
243
Insmed
INSM
$28.6B
$2.41M 0.02%
155,591
+95,057
+157% +$1.35M
HLT icon
244
Hilton Worldwide
HLT
$71.5B
$2.36M 0.02%
+30,133
New +$2.26M
AVDL
245
DELISTED
Avadel Pharmaceuticals
AVDL
$1.93M 0.01%
+112,492
New +$1.61M
XOMA
246
DELISTED
Xoma
XOMA
$1.69M 0.01%
23,586
+6,646
+39% +$569K
AMAT icon
247
Applied Materials
AMAT
$428B
$1.68M 0.01%
+67,557
New +$1.53M
LITS
248
Lite Strategy Inc
LITS
$30.9M
$1.51M 0.01%
17,704
+9,493
+116% +$1.25M
FOLD
249
DELISTED
Amicus Therapeutics
FOLD
$1.49M 0.01%
178,601
+140,585
+370% +$965K
AKRX
250
DELISTED
Akorn Inc
AKRX
$1.48M 0.01%
+40,916
New +$1.58M

Similar funds

Columbus Circle Investors's Q4 2014 Portfolio in Review

As of Q4 2014, Columbus Circle Investors held 357 positions worth $14.1B, up 1.5% from $13.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Columbus Circle Investors withdrew a net $745M in Q4 2014, closing 70 positions and reducing 104 holdings. Its most notable exit was Halliburton, an estimated $252M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Columbus Circle Investors opened a new position in Bath & Body Works worth $160M.

  • Columbus Circle Investors's largest Q4 2014 buy was Bath & Body Works: 2,284,351 shares worth $160M.
  • Columbus Circle Investors added most to Intuitive Surgical in Q4 2014, an estimated $101M increase.
  • Columbus Circle Investors's biggest Q4 2014 reduction was Biogen, cutting an estimated $177M.
  • Columbus Circle Investors fully exited Halliburton in Q4 2014, selling an estimated $252M.
  • Columbus Circle Investors's ten largest holdings make up 24% of its $14.1B portfolio in Q4 2014.
  • Columbus Circle Investors opened 97 new positions and closed 70 in Q4 2014.
  • Columbus Circle Investors's portfolio value rose 1.5% quarter-over-quarter to $14.1B.

Based on Columbus Circle Investors's 13F filing for Q4 2014, filed 5 Feb 2015.